We hosted our August virtual meeting on August 26, 2026, featuring an exceptional presentation by Marilyne Kpetemey, Ph.D., Medical Lead at AstraZeneca and a cancer biologist with extensive expertise in oncology drug development and medical affairs.
Dr. Kpetemey’s powerful talk emphasized a central truth: Africa does not need to wait for perfect infrastructure to make progress. By leveraging AI, local data, regional collaborations, and scalable diagnostic solutions, African nations can leap-frog traditional barriers and accelerate earlier detection, equitable access, and research inclusion.
The full slide deck is available in the resource section of our member portal.
Key Insights from the Session
Prostate Cancer Burden in Africa
- Although incidence appears lower than in Europe and the Americas, mortality is paradoxically higher across African countries due to late-stage diagnosis and limited diagnostic capacity.
- In many regions, prostate cancer is the most common cause of cancer-related death among men, underscoring the urgency of earlier detection and improved care pathways.
Late-Stage Presentation Drives Mortality
- 70–80% of African cancer patients are projected to present with Stage III/IV disease, where curative options are limited.
- Diagnostic delays—limited pathology, imaging, referral networks, and long wait times—push patients outside the curative window.
Why Early Detection Matters
- Earlier diagnosis is the inflection point between curative and palliative pathways.
- Strengthening screening, pathology, imaging, and referral systems can prevent 30–50% of late-stage presentations.
AI as a Catalyst for Change
- AI-enabled screening tools can expand early detection even in low-resource settings.
- Local data + AI can help Africa leap-frog infrastructure gaps, enabling:
- Improved risk stratification
- Faster diagnostic triage
- More equitable access to early detection
- Better clinical trial matching and recruitment
Precision Medicine Requires African Genomic Data
- 79% of global genomic studies are based on European ancestry, limiting applicability for African populations.
- Precision tools built on non-African datasets show 4.5-fold lower prediction accuracy in African populations.
- Initiatives like H3Africa demonstrate what African-led genomic research can achieve—biobanks, bioinformatics networks, ethical governance, and continent-wide scientific output.
Clinical Trial Underrepresentation
- In 2023, only 4% of global trials were hosted by African countries.
- Clinical trials offer a dual solution:
- Equitable patient access to advanced diagnostics and therapeutics
- Generation of diverse evidence needed for global drug development
Global Partnerships Are Essential
- Sustainable progress requires collaboration across:
- Health systems
- Academic institutions
- Industry and non-profits
- Partnerships can transform African sites from participants into co-leaders in global oncology research.
Questions Raised by Participants
“Most AI interventions in Africa stop after the pilot phase. Why?”
Sustainability requires local ownership, integration into existing workflows, and long-term funding models. Pilots often fail when they are not embedded into health systems.
“How can AI expand access to early detection and reduce disparities?”
AI can support point-of-care screening, triage, and remote diagnostics bringing high-quality detection tools closer to underserved communities.
“How do we engage young African men in their own healthcare?”
Education in basic biology, community-based outreach, and strengthening patient–physician relationships at the primary care level are essential. These are the same challenges that are populations in the West face.
“What is the future of cancer treatment if Africa remains underrepresented in clinical trials?”
Without representation, treatment guidelines may remain misaligned with African disease biology. AI can accelerate trial readiness by improving patient identification, data capture, and decentralized trial models.
“How can AI help accelerate clinical trial adoption across Africa?”
AI can streamline recruitment, support digital monitoring, and reduce operational barriers—making trials more feasible across diverse regions.
Take Action Today
Africa’s next contribution to global oncology will be shaped by collective small efforts, strategic partnerships, and the courage to innovate even before the system is perfect.
Join our growing movement at the African Healthcare Association by becoming a member today.
